
Keywords: ActRI; activin type-I receptor; ActRII; activin type-II recepto; ALK; activin receptor-like kinase; AR; androgen receptor; BMP; bone morphogenetic protein; BMPRI; BMP type-I receptor; BMPRII; BMP type-II receptor; DBH; dopamine-β-hydroxylase; DDC; 3,4-di